CAS 55512-99-7

N-carbamyl-dl-norvaline

Description:

N-carbamyl-dl-norvaline is an amino acid derivative characterized by its unique structure, which includes a carbamyl group attached to the side chain of dl-norvaline. This compound is often studied in biochemical and pharmaceutical contexts due to its potential role in metabolic processes and its implications in protein synthesis. It is a white to off-white crystalline solid that is soluble in water, making it suitable for various biological applications. The presence of the carbamyl group can influence its reactivity and interaction with other biomolecules. N-carbamyl-dl-norvaline may also exhibit properties that are relevant in the study of enzyme inhibition or as a substrate in metabolic pathways. As with many amino acid derivatives, its stability and reactivity can be affected by environmental conditions such as pH and temperature. Overall, N-carbamyl-dl-norvaline serves as an important compound in the field of biochemistry, particularly in studies related to amino acid metabolism and protein engineering.

Formula: C₆H₁₂N₂O₃

InChI: InChI=1/C6H12N2O3/c1-2-3-4(5(9)10)8-6(7)11/h4H,2-3H2,1H3,(H,9,10)(H3,7,8,11)

SMILES: CCCC(C(=O)O)NC(=N)O

Synonyms:

• N-carbamoylnorvaline

2-(Carbamoylamino)pentanoic acid

CAS: 55512-99-7

2-(Carbamoylamino)pentanoic acid is a monoclonal antibody that can be used as a diagnostic agent. It inhibits the proliferation of cancer cells by binding to the malic acid receptor, which is overexpressed on prostate cancer cells. This antibody has been shown to have an inhibitory effect on cell proliferation in vivo, but does not interfere with the function of other cells. 2-(Carbamoylamino)pentanoic acid also binds to antibodies and has shown a detection time of 4 hours in vivo. 2-(Carbamoylamino)pentanoic acid has been shown to bind to malic acid in vitro and can be used for the diagnosis of prostate cancer.

Formula: C₆H₁₂N₂O₃

Purity: Min. 95%

Molecular weight: 160.17 g/mol

Ref: 3D-FCA51299